✦ LIBER ✦

An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumors

✍ Scribed by Ychou, M.

Book ID: 121817255
Publisher: Oxford University Press
Year: 2003
Tongue: English
Weight: 126 KB
Volume: 14
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdg119

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I Study of Oxaliplatin in Combinat

Phase I Study of Oxaliplatin in Combination with Gemcitabine, Irinotecan, and 5-Fluorouracil/Leucovorin (G-FLIE) in Patients with Metastatic Solid Tumors Including Adenocarcinoma of the Pancreas

✍ Adam J. Olszewski, Michael L. Grossbard… 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 172 KB

Intravenous aflibercept administered in

Intravenous aflibercept administered in combination with irinotecan, 5-fluorouracil and leucovorin in patients with advanced solid tumours: Results from the expansion cohort of a phase I study

✍ Khayat, David; Tejpar, Sabine; Spano, Jean-Philippe; Verslype, Chris; Bloch, Joë 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 363 KB

A phase 1 study of hepatic arterial infu

A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver

✍ Apostolia M. Tsimberidou; Siqing Fu; Chaan Ng; Jo Ann Lim; Sijin Wen; David Hong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB 👁 1 views